Evidence map›Paper›PMID 41198389›Full record

ArticleThe European respiratory journal2025

Inhaled treprostinil improves cardiac output during exertion in interstitial lung disease.

Yogesh N V Reddy, Robert P Frantz, Alexander C Egbe, William R Miranda, Tomonari Harada, Tatsuro Ibe, Hilary M Dubrock, Hector Cajigas, Barry A Borlaug

Abstract readLetter
In one paragraph

Article in The European respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yogesh N V ReddyThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Robert P FrantzThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0003-4128-3978
Alexander C EgbeThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
William R MirandaThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Tomonari HaradaThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Tatsuro IbeThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Hilary M DubrockThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Hector CajigasThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.ORCID https://orcid.org/0000-0002-6792-1280
Barry A BorlaugThe Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.

Funding

Pulmonary Hypertension in Left Heart DiseaseR01HL162828 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug, Margaret M Redfield · 2023 to 2026
$3.1M
HL-Inorganic Nitrite to Enhance Benefits from Exercise Training in Heart Failure with preserved Ejection FractionR01HL128526 · NHLBI · MAYO CLINIC ROCHESTER · PI BORLAUG, BARRY A. · 2016 to 2019
$2.4M
Mayo Clinic HeartShare Clinical CenterU01HL160226 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug, Margaret M Redfield · 2021 to 2026
$1.8M
Peripheral Limitations in Pulmonary Hypertension and Effects of Muscle TrainingK23HL164901 · NHLBI · MAYO CLINIC ROCHESTER · PI Yogesh Nellore Vilambi Reddy · 2023 to 2026
$671k
NHLBI NIH HHS K23 HL164901NHLBI NIH HHS R01 HL128526NHLBI NIH HHS R01 HL162828NHLBI NIH HHS U01 HL160226
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41198389
PMCPMC12883151

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.